Israel Englander Chroma Dex Corp. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Millennium Management LLC holds 192,341 shares of CDXC stock, worth $698,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,341

Previous 584,282 67.08%

Holding current value

$698,197

Previous $2.03 Million 74.18%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.44 - $4.32 $956,336 - $1.69 Million	-391,941 Reduced 67.08%	192,341 $525,000
Q1 2024 May 15, 2024	BUY	$1.36 - $3.84 $624,492 - $1.76 Million	459,186 Added 367.07%	584,282 $2.03 Million
Q4 2023 Feb 14, 2024	SELL	$1.28 - $1.6 $199,650 - $249,563	-155,977 Reduced 55.49%	125,096 $178,000
Q2 2023 Aug 14, 2023	SELL	$1.31 - $1.79 $303,709 - $414,991	-231,839 Reduced 45.2%	281,073 $441,000
Q1 2023 May 15, 2023	SELL	$1.48 - $2.19 $221,933 - $328,401	-149,955 Reduced 22.62%	512,912 $785,000
Q4 2022 Feb 14, 2023	BUY	$1.25 - $1.94 $577,755 - $896,675	462,204 Added 230.34%	662,867 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.06 $669,886 - $1.16 Million	-562,930 Reduced 73.72%	200,663 $247,000
Q2 2022 Aug 15, 2022	BUY	$1.59 - $2.7 $1.21 Million - $2.06 Million	763,593 New	763,593 $1.28 Million
Q1 2022 May 16, 2022	SELL	$2.02 - $3.92 $456,358 - $885,606	-225,920 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.74 - $6.7 $272,466 - $488,108	72,852 Added 47.59%	225,920 $845,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.41 $307,642 - $529,348	50,850 Added 49.75%	153,068 $960,000
Q2 2021 Aug 16, 2021	SELL	$6.66 - $10.92 $5.37 Million - $8.81 Million	-806,695 Reduced 88.75%	102,218 $1.01 Million
Q1 2021 May 17, 2021	BUY	$4.59 - $18.74 $3.73 Million - $15.2 Million	812,958 Added 847.23%	908,913 $8.49 Million
Q4 2020 Feb 16, 2021	SELL	$3.93 - $5.5 $420,867 - $589,000	-107,091 Reduced 52.74%	95,955 $461,000
Q3 2020 Nov 16, 2020	BUY	$4.01 - $5.56 $417,027 - $578,223	103,997 Added 105.0%	203,046 $814,000
Q2 2020 Aug 14, 2020	BUY	$3.0 - $5.52 $297,147 - $546,750	99,049 New	99,049 $455,000
Q4 2019 Feb 14, 2020	SELL	$2.83 - $4.61 $437,894 - $713,319	-154,733 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.83 - $4.72 $513,162 - $632,409	133,985 Added 645.77%	154,733 $608,000
Q2 2019 Aug 15, 2019	SELL	$3.71 - $4.83 $135,990 - $177,043	-36,655 Reduced 63.86%	20,748 $96,000
Q2 2019 Aug 14, 2019	BUY	$3.71 - $4.83 $212,965 - $277,256	57,403 New	57,403 $5.25 Million
Q2 2018 Aug 14, 2018	SELL	$3.22 - $4.43 $1.62 Million - $2.24 Million	-504,525 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$4.05 - $6.46 $155,799 - $248,509	-38,469 Reduced 7.08%	504,525 $2.12 Million
Q4 2017 Feb 14, 2018	BUY	$3.88 - $6.96 $798,705 - $1.43 Million	205,852 Added 61.06%	542,994 $3.19 Million
Q3 2017 Nov 14, 2017	BUY	$2.91 - $4.71 $981,083 - $1.59 Million	337,142	337,142 $1.45 Million

Others Institutions Holding CDXC

# of Institutions

Shares Held

16.4M

Call Options Held

91.7K

Put Options Held

18.9K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $248M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account